Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Aug 7, 2026, 5:22 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 12.28 million as of August 10, 2026. Its market cap has decreased by -47.19% in one year.
Market Cap
12.28M
Enterprise Value
18.07M
Revenue
2.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 12.28M, a decrease of -80.74%. That is a compound annual growth rate of -19.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 12.28M | -30.43% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 27.37M |
| Lobe Sciences | 24.65M |
| Alzai Health | 22.77M |
| Devonian Health Group | 21.55M |
| Pharmala Biotech Holdings | 15.29M |
| Hemostemix | 13.85M |
| PreveCeutical Medical | 12.24M |
| Britannia Life Sciences | 10.55M |